Rapid POC Growth Credo Diagnostics Biomedical specializes in rapid molecular diagnostics at the point-of-care, presenting a clear sales opportunity to healthcare providers, clinics, and veterinary practices seeking quick, on-site pathogen detection to improve patient management and throughput.

Infectious Disease Focus The VitaPCR platform targets human infectious diseases and animal health, including SARS-CoV-2, influenza, and RSV, creating cross-market selling opportunities across human healthcare institutions and veterinary networks, as well as mixed-use clinics.

Small-to-Mid Market With 11-50 employees and a revenue range of 1–10 million dollars, there is room for early-stage partnerships and regional distributors to scale sales through focused account targets, clinical labs, and urgent care settings.

Cost-Effective Value Emphasize the cost savings and streamlined processes of rapid PCR-based POC testing to budget-conscious facilities, enabling pilots and small-scale deployments that can expand to larger districts or multi-site networks.

Multi-Sector Deployment Position VitaPCR for veterinary clinics, animal health distributors, and human healthcare providers to leverage dual-use capabilities, expanding upsell opportunities to clinics that already invest in rapid testing platforms.